Verition Fund Management
KITE

Verition Fund Management’s Kite Pharma, Inc. KITE Stock Holding History

Verition Fund Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,969
Closed -$714K – 1417
2017
Q3 		$714K Buy
+3,969
New +$553K 0.06% 412
2017
Q2 		– Sell
-3,062
Closed -$240K – 1479
2017
Q1 		$240K Sell
3,062
-2,274
-43% -$141K 0.02% 946
2016
Q4 		$239K Buy
+5,336
New +$262K 0.02% 955

Verition Fund Management's KITE Position: Q4 2017 in Review

Verition Fund Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 3,969 shares — an estimated $714K sold.

Verition Fund Management first reported a position in KITE in Q4 2016 and held it in 3 quarters. The position peaked at $714K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Verition Fund Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Verition Fund Management sold 3,969 Kite Pharma, Inc. shares in Q4 2017, an estimated $714K.
  • Verition Fund Management first reported a position in Kite Pharma, Inc. in Q4 2016 and held it in 3 quarters.
  • Verition Fund Management's Kite Pharma, Inc. position peaked at $714K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Verition Fund Management's 13F filing for Q4 2017, filed 15 Feb 2018.